| __timestamp | Alpine Immune Sciences, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 24518692 |
| Thursday, January 1, 2015 | 6844000 | 19886580 |
| Friday, January 1, 2016 | 8586000 | 12631689 |
| Sunday, January 1, 2017 | 6079000 | 21977998 |
| Monday, January 1, 2018 | 8362000 | 20759000 |
| Tuesday, January 1, 2019 | 9467000 | 20838000 |
| Wednesday, January 1, 2020 | 10899000 | 121812000 |
| Friday, January 1, 2021 | 14560000 | 152137000 |
| Saturday, January 1, 2022 | 17968000 | 83231000 |
| Sunday, January 1, 2023 | 22222000 | 122706000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing operational costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of TG Therapeutics, Inc. and Alpine Immune Sciences, Inc. from 2014 to 2023. Over this period, TG Therapeutics consistently outspent Alpine Immune Sciences, with expenses peaking at approximately $122 million in 2023, a staggering 400% increase from 2014. In contrast, Alpine Immune Sciences saw a more modest rise, with expenses growing nearly tenfold to $22 million in 2023. This divergence highlights the differing strategic approaches of these companies, with TG Therapeutics investing heavily in growth and Alpine Immune Sciences maintaining a leaner operation. As the biotech industry continues to evolve, these financial strategies will play a pivotal role in shaping the future of these innovative companies.
Johnson & Johnson and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
Merck & Co., Inc. or Alpine Immune Sciences, Inc.: Who Manages SG&A Costs Better?
Amgen Inc. and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Alpine Immune Sciences, Inc.
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and PTC Therapeutics, Inc.
Breaking Down SG&A Expenses: TG Therapeutics, Inc. vs Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: TG Therapeutics, Inc. vs ImmunityBio, Inc. Trends and Insights
Selling, General, and Administrative Costs: Alpine Immune Sciences, Inc. vs Agios Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Alpine Immune Sciences, Inc. or Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Evotec SE